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Abstract
Background: The Institute of Medicine recommends Survivorship Care Plans (SCPs) for all cancer survivors. However, it is
unclear whether certain patient groups may or may not benefit from SCPs.
Objective: The aim was to assess whether the effects of an automatically generated paper SCP on patients’ satisfaction with
information provision and care, illness perceptions, and health care utilization were moderated by disease-related Internet use.
Methods: Twelve hospitals were randomized to either SCP care or usual care in the pragmatic cluster randomized
Registrationsystem Oncological GYnecology (ROGY) Care trial. Newly diagnosed endometrial cancer patients completed
questionnaires after diagnosis (N=221; response: 74.7%, 221/296), 6 months (n=158), and 12 months (n=147), including patients’
satisfaction with information provision and care, illness perceptions, health care utilization (how many times patients visited a
medical specialist or primary care physician about their cancer in the past 6 months), and disease-related Internet use (whether
patients used the Internet to look for information about cancer).
Results: In total, 80 of 221 (36.2%) patients used the Internet to obtain disease-related information. Disease-related Internet
use moderated the SCP care effect on the amount of information received about the disease (P=.03) and medical tests (P=.01),
helpfulness of the information (P=.01), and how well patients understood their illness (P=.04). All stratified analyses were not
statistically significant. However, it appeared that patients who did not seek disease-related information on the Internet in the
SCP care arm reported receiving more information about their disease (mean 63.9, SD 20.1 vs mean 58.3, SD 23.7) and medical
tests (mean 70.6, SD 23.5 vs mean 64.7, SD 24.9), finding the information more helpful (76.7, SD 22.9 vs mean 67.8, SD 27.2;
scale 0-100), and understanding their illness better (mean 6.6, SD 3.0 vs mean 6.1, SD 3.2; scale 1-10) than patients in the usual
care arm did. In addition, although all stratified analyses were not significant, patients who did seek disease-related information
on the Internet in the SCP care arm appeared to receive less information about their disease (mean 65.7, SD 23.4 vs mean 67.1,
SD 20.7) and medical tests (mean 72.4, SD 23.5 vs mean 75.3, SD 21.6), did not find the information more helpful (mean 78.6,
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SD 21.2 vs mean 76.0, SD 22.0), and reported less understanding of their illness (mean 6.3, SD 2.8 vs mean 7.1, SD 2.7) than
patients in the usual care arm did.
Conclusions: Paper SCPs appear to improve the amount of information received about the disease and medical tests, the
helpfulness of the information, and understanding of the illness for patients who do not search for disease-related information on
the Internet. In contrast, paper SCPs do not seem beneficial for patients who do seek disease-related information on the Internet.
Trial Registration: ClinicalTrials.gov NCT01185626; https://clinicaltrials.gov/ct2/show/NCT01185626 (Archived by WebCite
at http://www.webcitation.org/6fpaMXsDn)
(J Med Internet Res 2016;18(7):e162)   doi:10.2196/jmir.4914
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Introduction
Information provision has been demonstrated to play an essential
role in the support for cancer survivors [1,2]. To improve patient
information provision, the Institute of Medicine (IOM)
recommends the use of Survivorship Care Plans (SCPs),
described as personal treatment summaries and follow-up care
plans, for all cancer survivors [3]. However, there is still an
ongoing debate about the benefits of SCPs [4-12].
Recent results of the pragmatic cluster randomized
Registrationsystem Oncological GYnecology (ROGY) Care
trial [8], in which cancer patients were provided with a
paper-based SCP, showed that SCPs increased the amount of
information received. However, the trial showed no evidence
of SCPs benefitting satisfaction with information and care.
Furthermore, SCPs increased patients’ concerns, emotional
impact, experienced symptoms, and the amount of cancer-related
contact with the primary care physician. Moreover, it remains
unclear whether patient characteristics influence the effects of
SCPs and whether certain groups of patients may or may not
benefit from SCPs [8].
The SCPs are usually provided by patients’ health care
providers, who are patients’ main source of information about
their cancer [1,13]. However, the Internet is also increasingly
used as a source of information. Several studies have shown
that a significant proportion of cancer survivors, ranging from
30% to 60%, are using the Internet to seek information about
their cancer [14-19]. Especially those cancer survivors who are
younger [15,17,19], higher educated [15,17,19], male [15], and
have a partner [19] use the Internet.
Using the Internet to obtain disease-related information has
been associated with considerable benefits for cancer survivors
[20]. For instance, it has been found that cancer survivors who
use the Internet to access disease-related information feel better
informed [15], report receiving more information about their
disease and medical tests [21], find the received information
more helpful [21], communicate more effectively with their
health care providers [22], and are more actively involved in
decision making [23]. Therefore, it is possible that receiving an
SCP has a different impact on patients who search for
information about their cancer on the Internet compared to
patients who do not search for information about their cancer
on the Internet.
The ROGY Care trial evaluates the impact of an automatically
generated SCP on outcomes reported by gynecological cancer
patients and health care providers. The trial protocol [24], the
primary patient-reported outcomes up to 12 months after
diagnosis [8], and the evaluation of the oncology providers [28]
and primary care physicians [46] have been previously
described. The aim of this analysis of the ROGY Care trial was
to assess whether the effects of an automatically generated paper
SCP on patients’ satisfaction with information provision and
care, illness perceptions, and health care utilization were
moderated by (ie, different for) disease-related Internet use. It
was hypothesized that paper SCPs may be a helpful tool to reach
out to patient groups who do not search for information about
their cancer on the Internet, whereas SCPs may be of limited
value for patients who already benefit from accessing
information about their cancer on the Internet.
Methods
Design
In the pragmatic cluster randomized controlled ROGY Care
trial, 12 hospitals in the Netherlands were randomized to either
SCP care or usual care. Patients were included immediately
after initial surgery and followed for 24 months. The trial was
centrally approved by the Medical Research Ethics Committee
of the St Elisabeth Hospital in Tilburg, as well as by the Medical
Research Ethics Committees of each participating center [24],
and has been registered on ClinicalTrials.gov (NCT01185626).
This study describes the results of subgroup analyses of the
primary patient-reported outcomes up to 12 months after
diagnosis.
Participants and Recruitment
Participants were women newly diagnosed with endometrial
cancer. Exclusion criteria (ie, undergoing palliative care or
unable to complete a Dutch questionnaire) [24] were minimal
to maximize generalizability [25]. Between April 2011 and
October 2012, all eligible patients were invited to participate
after initial diagnosis by their own gynecologist by sending a
letter, questionnaire, and informed consent form [8,24]. After
the first contact through the gynecologist and obtaining informed
consent, follow-up questionnaires were sent directly to the home
address of the patient at 6 and 12 months after diagnosis .
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Randomization and Blinding
Randomization at the hospital level was chosen to avoid
potential contamination of usual care with increased information
provision of SCP care and was performed with a table of random
numbers by a researcher not involved in the study and blind to
the identity of the hospitals. As is common in cluster randomized
trials [27], patients were unaware of the assignment to trial arms.
Health care providers could not be blinded to trial arm
assignment.
Survivorship Care Plan Versus Usual Care
In the usual care arm, the oncology providers (ie, gynecologists,
gynecologic oncologists, oncology nurses) were instructed to
continue providing patient information in the way they were
used to: they gave standard care according to the Dutch
follow-up guidelines, which recommend verbal and written
information about the period after treatment and follow-up,
signs of recurrence, and hospital contact details. None of the
oncology providers in the usual care arm provided SCPs [28].
In the SCP care arm, the oncology providers were instructed to
provide an SCP to patients after surgery (ie, during the
consultation in which the final histological diagnosis was
discussed); to provide an updated SCP during follow-up visits
if there were changes in the cancer, treatment, or specialists;
and to send a copy of the SCP to the patient’s primary care
physician. Because of the pragmatic approach of the trial, the
delivery of the intervention was allowed to vary between
hospitals and oncology providers, fitting their own clinical
practice [24].
Survivorship Care Plan
The Web-based ROGY has been used by all participating
oncology providers in both arms since 2006. For each patient,
a detailed registration is made in a uniform way, including tumor
stage and grade, treatment, comorbidity, complications,
follow-up, and information about the involved specialists (eg,
gynecologist/gynecologic oncologist, medical oncologist,
radiation oncologist). For this trial, an application was built in
ROGY enabling automatic generation of an SCP combining
patient and disease data by simply pressing a button. The ROGY
system was used by all participating oncology providers in both
arms, but the SCP button was only visible for oncology
providers in the SCP care arm. Any changes related to the
cancer, treatment, or specialists were registered in ROGY and
automatically updated in the SCP during follow-up.
For the development of the SCP, the Dutch SCP template (based
on the IOM format) [3], was adjusted to the local situation [29]
by a subgroup of gynecologists/gynecologic oncologists,
oncology nurses, a radiation oncologist, a medical oncologist,
a primary care physician, and patients [24]. The SCP was
pilot-tested on patients with a low/intermediate educational level
to ensure that the SCP was understandable.
The SCP consisted of a tailored treatment summary, including
information on diagnostic tests, type of cancer, stage, grade,
treatment, and contact details of the hospital and specialists. In
addition, the SCP contained a tailored follow-up care plan,
including detailed information on possible short-term and
long-term effects, effects on social and sexual life, possible
signs of recurrence and secondary tumors, and information on
rehabilitation, psychosocial support, and supportive care services
[24].
Measures
All questionnaires were assessed after initial diagnosis and after
6 and 12 months.
Moderator Variable
Disease-related Internet use was assessed by asking whether
patients had used the Internet to look for information about
cancer, which could be answered by either yes or no.
Dependent Variables
Satisfaction with information provision was assessed with the
European Organisation for Research and Treatment of Cancer
(EORTC) Quality of Life Group information (QLQ-INFO25)
questionnaire [30]. This questionnaire includes four information
provision subscales: perceived receipt of information about the
disease (four items regarding diagnosis, spread of disease,
cause(s) of disease, and whether the disease is under control),
medical tests (three items regarding purpose, procedures, and
results of tests), treatment (six items regarding medical
treatment, benefits, side effects, effects on disease symptoms,
social life, and sexual activity) and other care services (four
items regarding additional help, rehabilitation options, managing
illness at home, psychological support). The question format
was as follows: “During your current disease or treatment, how
much information have you received on...?” In addition, four
single-items were included (information about different places
of care, things you can do to help yourself get well, satisfaction
with the information, and helpfulness of the information). The
answer categories were “not at all,” “a little,” “quite a bit,” and
“very much.” The scales were converted to 0-100 linear scales,
with higher scores indicating better-perceived information
provision. Internal consistency for all scales (Cronbach
alphas=.70-.87) and test-retest reliability (intraclass
correlations=.71-.91) were good [30].
Satisfaction with care was assessed with two multi-item and
two single-item scales of the EORTC cancer in-patient
satisfaction with care measure (IN-PATSAT32) [31]. This
questionnaire was designed to assess cancer patients’ perception
of the quality of medical care, nursing care, and care
organization and services received in the hospital. The
multi-item scales included doctors’ and nurses’ interpersonal
skills. The single-item scales included exchange of information
between caregivers and general satisfaction with care. The
question format was as follows: “How would you rate...?” The
answer categories were “poor,” “fair,” “good,” “very good,”
and “excellent.” The scales were converted to 0-100 linear
scales, with higher scores indicating better-perceived quality of
care. Internal consistency (Cronbach alphas=.67-.96) and
test-retest reliability (intraclass correlations=.66-.85) were good
[31].
Illness perception was assessed with the Brief Illness Perception
Questionnaire (B-IPQ) [32], consisting of eight single-item
scales, measuring cognitive representations (consequences,
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timeline, personal control, treatment control, identity), emotional
representations (concern, emotion), and illness comprehensibility
rated on a 0-10 linear scale, with higher scores indicating more
endorsement of that item. Test-retest reliability (Pearson
correlations=.42-.75) was good [32].
Health care utilization was assessed by asking how many times
patients visited a medical specialist or primary care physician
in relation to cancer in the past 6 months. These questions were
asked in a similar way as is done by Statistics Netherlands.
Control Variables
Sociodemographic and clinical information were obtained from
ROGY (ie, date of birth, date of diagnosis, disease stage, primary
treatment) and the questionnaire (ie, marital status, educational
level as an indicator for socioeconomic status [SES],
employment status). Comorbidity was assessed by the adapted
Self-administered Comorbidity Questionnaire (SCQ) [33].
Statistical Analyses
Statistical analyses were conducted using SPSS version 19.0
(IBM Corp, Armonk, NY, USA). Tests were two-sided and
considered significant if P<.05. Both intention-to-treat and per
protocol analyses were conducted. Intention-to-treat analyses
compared all respondents in the SCP care arm to all respondents
in the usual care arm. Per protocol analyses compared
respondents in the SCP care arm who indicated receiving an
SCP in the first questionnaire to all respondents in the usual
care arm. Because intention-to-treat and per protocol analyses
revealed similar results, only the results of the intention-to-treat
analyses are reported in this study.
Means with standard deviations were used to describe
continuous variables and frequencies with percentages to
describe categorical variables. Differences in sociodemographic
and clinical characteristics between respondents and
nonrespondents, between the SCP care arm and the usual care
arm, and between patients who did or did not use the Internet
to obtain information about their disease were compared using
t tests for continuous variables and chi-square tests for
categorical variables.
Moderation of disease-related Internet use on the dependent
variables (ie, 22 scales in total: eight on information provision,
four on satisfaction with care, eight on illness perceptions, and
two on health care utilization) was tested by assessing the
significance of the interaction term “trial arm × disease-related
Internet use” in the overall linear multilevel regression model.
Multilevel analysis corrects for missing data (assumed missing
at random) by using information from the observed outcomes
to provide information about the unobserved outcomes [34,35]
The model included two random intercepts (ie, hospital- and
patient-level) to account for both clustering at hospital-level
and intrapatient dependency of repeated measures [36], the
independent variables intervention arm (ie, SCP care vs usual
care) and time, the covariates age, time since diagnosis, marital
status, employment, educational level, comorbidity, disease
stage, and treatment, and the dependent variables information
provision and care, illness perceptions, and health care
utilization. For the models that did not converge, hospital was
included as covariate instead of as random intercept [37].
When an interaction term was significant, this was an indication
that the effect of providing an SCP was different for patients
who did or did not use the Internet to search for disease-related
information and that stratified analyses were warranted to further
explore the direction of the moderation effects. For significant
interaction terms, the intervention effects were re-examined in
subgroups by performing the overall linear multilevel regression
analyses stratified by the levels of the moderator variable (ie,
disease-related Internet use). Unstandardized betas were
presented with 95% confidence intervals.
The trial was originally powered to detect a clinically meaningful
difference on the overall primary outcomes of the intervention,
targeting 75 patients per arm [8,24]. The trial was not powered
to detect differences in moderation analyses or stratified
analyses. In this study, moderation analyses and stratified
analyses were performed despite this lack of power because we
merely wanted to explore the potential moderating role of
Internet use. These analyses can be justified because they are
exploratory and because the exploration was a priori restricted
to a selected moderator with a specific rationale [38].
Results
Patient Characteristics
Of the 296 eligible patients, 221 (74.7%) patients completed
the first questionnaire. After 6 months, 158 patients completed
the questionnaire; after 12 months, 147 patients completed the
questionnaire (Figure 1) [8].
At baseline, participants were younger (mean 67.4, SD 8.9 years)
than nonparticipants (mean 70.2, SD 9.5 years, P=.02), and
more often had an International Federation of Gynecology and
Obstetrics (FIGO) staging level of stage I (85.5%, 189/221 vs
69%, 52/75; P=.003; Table 1) [8]. In total, 80 of 221 (36.2%)
patients indicated that they used the Internet to obtain
information about their disease. This did not differ between the
SCP care arm and the usual care arm (Table 2).
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Table 1. CONSORT table of baseline sociodemographic and clinical characteristics of participants according to trial arm and of nonparticipants.
P aNonparticipants
(n=75)
Total participants
(N=221)
P aUsual care
(n=102)
SCP care
(n=119)
Patient characteristics
.0270.2 (9.5)67.4 (8.9).6567.7 (8.8)67.1 (9.1)Age at diagnosis, mean (SD)
FIGO stage, n (%)
.00352 (69)189 (85.5).7587 (85.3)102 (85.7)I
10 (13)7 (3.2)2 (2.0)5 (4.2)II
11 (15)15 (6.8)7 (6.8)8 (6.7)II
1 (1)7 (3.2)4 (3.9)3 (2.9)IV
Treatment, n (%)
.4572 (96)214 (96.8).4697 (95)117 (98.3)Surgery
.1934 (45)81 (36.7).9937 (36.3)44 (37.0)Radiotherapy
.767 (9)18 (8.1).0612 (11.8)6 (5.0)Chemotherapy
Hospital, n (%)
.614 (5)22 (10.0)22 (18.5)1
7 (9)12 (5.4)12 (10.1)2
9 (12)28 (12.7)28 (23.5)3
9 (12)28 (12.7)28 (23.5)4
1 (1)11 (5.0)11 (9.2)5
5 (7)18 (8.1)18 (15.1)6
13 (17)25 (11.3)25 (24.5)7
6 (8)21 (9.5)21 (20.5)8
7 (9)26 (11.8)26 (25.5)9
4 (5)12 (5.4)12 (11.8)10
3 (4)3 (1.4)3 (2.9)11
7 (9)15 (6.8)15 (14.7)12
aP values report comparisons between the intervention arm and the usual care arm, and between the trial participants and nonparticipants according to
t tests and chi-square tests.
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Table 2. Sociodemographic and clinical characteristics at the first questionnaire according to trial arm.
Total (N=221)P aUsual care (n=102)SCP care (n=119)Patient characteristics
67.6 (9.0).7167.8 (8.9)67.4 (9.1)Age at time of survey,
mean (SD)
2.1 (1.5)<.0011.8 (1.2)2.6 (1.7)Months since diagnosis,
mean (SD)
Months since diagnosis, n (%)
36 (16.3)24 (23.5)12 (10.1)<1
86 (38.9)46 (45.0)40 (33.6)1-2
53 (24.0)20 (19.6)33 (27.7)2-3
46 (20.8)12 (11.8)34 (28.6)>3
.41Comorbidity, n (%)
37 (16.7)18 (17.6)19 (16.0)None
52 (23.5)20 (19.6)32 (26.9)1
126 (57.0)62 (60.8)64 (53.8)≥2
.74Marital status, b n (%)
161 (72.9)76 (74.5)85 (71.4)Partner
56 (25.3)25 (24.5)31 (26.1)No partner
.09Educational level,cn (%)
24 (10.9)7 (6.9)17 (14.3)High
143 (64.7)72 (70.6)71 (59.7)Intermediate
49 (22.2)19 (18.6)30 (25.2)Low
.40Employed, n (%)
37 (16.7)15 (14.7)22 (18.5)Yes
164 (74.2)79 (77.5)85 (71.4)No
.57Disease-related Internet use, n (%)
80 (36.2)39 (38.2)41 (34.5)Yes
136 (61.5)60 (58.8)76 (63.9)No
aP values report comparisons between the intervention arm and the usual care arm, according to t tests and chi-square tests.
bMarital status: partner=married/living together, no partner=divorced/widowed/never married.
cEducational level: low=no/primary school, intermediate=lower general secondary education/vocational training, high=preuniversity education/ high
vocational training/university.
Patients who used the Internet to obtain disease-related
information were younger (mean 62.8, SD 7.5 years) than
patients who did not use the Internet to obtain disease-related
information (mean 70.3, SD 8.7 years; Table 3). In addition,
patients who used the Internet to obtain disease-related
information more often had a partner (83%, 66/80 vs 67.6%,
92/136), more often had a high educational level (20%, 16/80
vs 5.1%, 7/136), and were employed more often (28%, 21/80
vs 11.8%, 16/136) than patients who did not use the Internet to
obtain disease-related information.
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Table 3. Patient characteristics at the first questionnaire according to disease-related Internet use.
Total (N=216)P aNo disease-related Inter-
net use (n=136)
Disease-related Internet use (n=80)Patient characteristics
67.5 (9.0)<.00170.3 (8.7)62.8 (7.5)Age at time of survey, mean (SD)
2.2 (1.5).102.3 (1.6)2.0 (1.3)Months since diagnosis, mean (SD)
Months since diagnosis, n (%)
35 (16.2)16 (11.8)19 (24)<1
84 (38.9)53 (39.0)31 (39)1-2
53 (24.5)41 (30.1)12 (15)2-3
44 (20.4)26 (19.1)18 (23)>3
.37FIGO stage, n (%)
185 (85.6)115 (84.6)70 (88)I
7 (3.2)3 (2.2)4 (5)II
15 (6.9)12 (8.8)3 (4)II
6 (2.8)4 (2.9)2 (3)IV
Treatment, n (%)
209 (96.8).90132 (97.1)77 (96)Surgery
80 (37.0).3154 (39.7)26 (33)Radiotherapy
17 (7.9).7010 (7.4)7 (9)Chemotherapy
.20Comorbidity, n (%)
37 (17.1)19 (14.0)18 (23)None
50 (23.1)35 (25.7)15 (19)1
123 (56.9)78 (57.4)45 (56)≥2
.01Marital status, b n (%)
158 (73.1)92 (67.6)66 (83)Partner
54 (25.0)42 (30.9)12 (15)No partner
<.001Educational level, c n (%)
23 (10.6)7 (5.1)16 (20)High
142 (65.7)83 (61.0)59 (74)Intermediate
47 (21.8)42 (30.9)5 (6)Low
.01Employed, n (%)
37 (17.1)16 (11.8)21 (28)Yes
161 (74.5)107 (78.7)54 (72)No
aP values report comparisons between patients reporting disease-related Internet use and patients not reporting disease-related Internet use according
to t tests and chi-square tests.
bMarital status: partner=married/living together, no partner=divorced/widowed/never married.
cEducational level: low=no/primary school, intermediate=lower general secondary education/vocational training, high=preuniversity education/high
vocational training/university.
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Figure 1. CONSORT flow diagram of the progress of the hospitals and endometrial cancer patients through the phases of the ROGY Care trial. ITT:
intention-to-treat analyses (comparing all respondents in the SCP care arm to all respondents in the usual care arm); PP: per protocol analyses (comparing
the respondents in the SCP care arm who indicated that they received an SCP in the first questionnaire to all respondents in the usual care arm).
Moderation of Disease-Related Internet Use
Four statistically significant moderation tests were found.
Disease-related Internet use moderated the intervention effect
on the amount of information received about the disease (P=.03),
the amount of information received about medical tests (P=.01),
the helpfulness of the information (P=.01), and how well patients
understand their illness (P=.04). All other interaction terms were
not significant.
Although the stratified analyses were all not statistically
significant, it appeared that patients who did not seek
disease-related information on the Internet may have benefitted
from receiving an SCP because patients in the SCP care arm
reported receiving more information about their disease (mean
63.9, SD 20.1 vs mean 58.3, SD 23.7) and medical tests (mean
70.6, SD 23.5 vs mean 64.7, SD 24.9), found the information
more helpful (mean 76.7, SD 22.9 vs mean 67.8, SD 27.2), and
understood their illness better (mean 6.6, SD 3.0 vs mean 6.1,
SD 3.2) than patients in the usual care arm did (Table 4 and
Figures 2-5). On the other hand, although the stratified analyses
were all not statistically significant, it appeared that patients
who did seek disease-related information on the Internet did
not benefit from receiving an SCP because patients in the SCP
care arm did not report receiving more information about their
disease (mean 65.7, SD 23.4 vs mean 67.1, SD 20.7) and
medical tests (mean 72.4, SD 23.5 vs mean 75.3, SD 21.6), did
not find the information more helpful (mean 78.6, SD 21.2 vs
mean 76.0, SD 22.0), and reported less understanding of their
illness (mean 6.3, SD 2.8 vs mean 7.1, SD 2.7) than patients in
the usual care arm did (Table 4 and Figures 2-5).
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Table 4. Regression outcomes from the stratified analyses for the effect of SCP care on the outcomes according to disease-related Internet use.
PBeta (95% CI)cTotal, mean (SD)Usual care, mean
(SD)b
SCP care, mean
(SD)b
Outcomea
Information disease d
.79–1.36 (–12.7, 10.0)66.4 (22.1)67.1 (20.7)65.7 (23.4)Internet use
.225.51 (–3.9, 14.9)61.4 (21.9)58.3 (23.7)63.9 (20.1)No Internet use
Information medical tests d
.43–3.83 (–13.5, 5.8)73.9 (22.6)75.3 (21.6)72.4 (23.5)Internet use
.244.87 (–3.3, 13.0)68.0 (24.3)64.7 (24.9)70.6 (23.5)No Internet use
Helpfulness information d
.791.13 (–7.4, 9.6)77.3 (21.6)76.0 (22.0)78.6 (21.2)Internet use
.116.89 (–1.6, 15.4)72.9 (25.2)67.8 (27.2)76.7 (22.9)No Internet use
How well understand illness e
.09–0.98 (–2.11, 0.14)6.7 (2.8)7.1 (2.7)6.3 (2.8)Internet use
.560.30 (–0.73, 1.33)6.3 (3.1)6.1 (3.2)6.6 (3.0)No Internet use
aOutcomes are presented only for the statistically significant interaction terms. Linear multilevel regression analyses were performed, adjusted for age,
time since diagnosis, marital status, educational level, employment, comorbidities, stage, and treatment. For the models that did not converge, hospital
was included as covariate instead of random intercept.
bCrude means and standard deviations are reported for SCP care and usual care.
cUnstandardized betas and 95% confidence intervals are reported for SCP care (ref=usual care).
dEORTC-QLQ-INFO25 scale range from 0-100: higher scores reflect better-perceived information received.
eB-IPQ scale range from 1-10: higher scores indicate more endorsement of that item.
Figure 2. Patients’ reported amount of information received about their disease according to disease-related Internet use for the SCP care and the usual
care arms. Crude means are reported. Error bars represent +1 SD. EORTC-QLQ-INFO25 scale ranges from 0-100 (higher scores reflect better perceived
information received).
J Med Internet Res 2016 | vol. 18 | iss. 7 | e162 | p.9http://www.jmir.org/2016/7/e162/
(page number not for citation purposes)
Nicolaije et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Figure 3. Patients’ reported amount of information received about their medical tests according to disease-related Internet use for the SCP care and
the usual care arms. Crude means are reported. Error bars represent +1 SD. EORTC-QLQ-INFO25 scale ranges from 0-100 (higher scores reflect better
perceived information received).
Figure 4. Patient-reported helpfulness of the information received according to disease-related Internet use for the SCP care arm and the usual care
arm. Crude means are reported. Error bars represent +1 SD. EORTC-QLQ-INFO25 scale ranges from 0-100 (higher scores reflect better-perceived
information received).
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Figure 5. Patients’ reported understanding of their illness according to disease-related Internet use for the SCP care and the usual care arms. Crude
means are reported. Error bars represent +1 SD. B-IPQ scale ranges from 1-10 (higher scores indicate more endorsement of that item).
Discussion
The results of this secondary analysis of the ROGY Care trial
suggest that paper-based SCPs appear to improve the amount
of received information about the disease and medical tests, the
helpfulness of the information, and the understanding of the
illness for patients who do not search for information on the
Internet themselves. In contrast, paper-based SCPs do not appear
helpful for patients who already search for information on the
Internet themselves. All other outcomes did not differ for
patients who did or did not use the Internet to search for
disease-related information.
Patients Who Did Not Use the Internet to Search for
Disease-Related Information
Nearly two-thirds of all patients in this study did not use the
Internet to search for disease-related information. These patients
were older, lower educated, and less often had a partner or a
job than patients who did use the Internet to search for
information about their cancer. This has consistently been found
in previous studies [15,17,19] and has raised the concern that
some patient groups do not equally benefit from the various
resources available on the Internet [19]. Because educational
level is an indicator for SES [39,40], patients with a higher SES
search the Internet more for disease-related information than
patients with a lower SES. This “digital divide” may pose a
threat to equity in health care when important information can
only be or best be accessed online [19]. Even today, a large
number of cancer survivors do not have access to the potential
benefits of the Internet. The results of this study suggest that
paper-based SCPs may be a useful tool to empower this patient
group by increasing the amount of information they receive
about their disease and medical tests, the helpfulness of the
information, and their understanding of their illness.
Patients Who Did Use the Internet to Search for
Disease-Related Information
A third of all patients in this study did use the Internet to search
for disease-related information, which is consistent with previous
studies [14-19]. The results of this study suggest that
paper-based SCPs may not be of added value for this patient
group. A possible explanation for this finding could be that
these patients already benefit from accessing information on
the Internet because using the Internet to obtain disease-related
information has been associated with considerable benefits for
cancer survivors [20]. Previous studies have found that cancer
survivors who use the Internet to access disease-related
information feel better informed [15], report receiving more
information about their disease and medical tests [21], find the
received information more helpful [21], communicate more
effectively with their health care providers [22], and are more
actively involved in decision making [23].
Surprisingly, the results of this study suggest that paper-based
SCPs may actually even decrease patients’ understanding of
their illness for those patients who search for disease-related
information on the Internet. A possible explanation could be
that patients who receive an SCP and also search for information
on the Internet may find information on the Internet about their
illness that conflicts with information within the SCP. This may
confuse patients and may lower their understanding of the
illness. Because these patients have access to more information,
they may also be more aware of aspects of their illness that they
do not (completely) understand (ie, the more you know, the
more you realize how little you know). Future research needs
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to investigate why SCPs may not be helpful for patients who
search for disease-related information on the Internet. Another
possibility is that paper-based SCPs in their current form are
not suitable for patients who search for disease-related
information on the Internet. A possible way to increase the value
of SCP care for patients who search for disease-related
information on the Internet may be to provide these patients
with access to a tailored online SCP instead of a paper-based
SCP. Previous research showed that most patients who use the
Internet prefer to get their information from reliable websites,
such as their hospital’s website, and would like to have online
access to their own medical file and test results [15].
Internet-based SCPs may be a useful way to support these
patients in finding reliable information online that is tailored to
their specific situation. The results of previous studies
investigating cancer patients’ satisfaction with an Internet-based
SCP tool seem promising [41-43]. Future research needs to
examine whether dissemination of tailored online SCPs does
have added value for patients who search for cancer-related
information on the Internet.
Considerations
It is important to take into consideration that this study was
conducted in the Netherlands, a developed country where 95%
of the population has access to the Internet at home [44].
Furthermore, only endometrial cancer patients were included
in this study. In general, endometrial cancer patients have a
lower educational level than patients with other types of cancer
[45] and lower educational levels have been found to be strongly
associated with lower Internet use [15,17,19]. In addition, men
tend to use the Internet more often than women [15].
Consequently, the percentage of patients who used the Internet
to search for disease-related information in this study may be
an underestimation of the Internet use of cancer survivors in
the Netherlands. A previous study conducted in the Netherlands
in 2006 that included both male and female patients with
different types of cancer found that 60% reported using the
Internet by themselves [15].
Other effects of SCP care found in the ROGY Care trial [8],
such as increased concerns about the illness, emotional impact,
experienced symptoms, and health care utilization, did not differ
for patients who did or did not use the Internet to search for
disease-related information. This finding indicates that SCPs
increase patients’ concerns, emotional impact, experienced
symptoms, and health care utilization for both patients who do
and do not search for disease-related information on the Internet.
It is possible that certain aspects of the SCP that are not found
on the Internet (eg, receiving information from the physician,
receiving personalized information, and receiving information
about additional care) lead to increased concerns, emotional
impact, experienced symptoms, and health care utilization.
However, it is important to consider that the ROGY Care trial
was not originally powered to detect differences in moderation
analyses or stratified analyses. Therefore, it is unclear whether
insignificant outcomes in these analyses indicate that
disease-related Internet use did not moderate these outcomes
or that the power was merely too small to find the effects. On
the other hand, this does make the moderation effects that were
found in this study more convincing.
Strengths and Limitations
A limitation of this study is that self-reported information
provision and health care utilization were assessed, which makes
it unclear how much information was actually provided and
how much health care was actually used. In addition, Internet
utilization was measured with a single dichotomous item.
Consequently, this study can only make a distinction between
patients who did or did not use the Internet to search for
disease-related information. For instance, it remains unknown
how many times patients searched the Internet, what they
searched for (ie, did they use the Internet to search for similar
topics as addressed in the SCP?), or what information they
found. For future research, we recommend using a more
elaborate measure of Internet utilization that is psychometrically
tested.
Despite these limitations, this study provides important new
insight into whether certain groups of patients may or may not
benefit from paper-based SCPs in routine clinical practice. The
pragmatic cluster randomized design, limited exclusion criteria,
and high response rate improve the generalizability of the
findings. However, there is not enough evidence to recommend
that patients who search for information on the Internet should
not receive a paper-based SCP. More research is needed to get
a more nuanced understanding of these findings before health
care providers can use the information to decide whether
providing a paper-based SCP is of added value or not. In
addition, future research needs to examine whether other patient
characteristics could also possibly influence the impact of SCPs.
Conclusions
The results of this secondary analyses of the ROGY Care trial
suggest that paper-based SCPs may improve the amount of
received information about the disease and medical tests, the
helpfulness of the information, and the understanding of the
illness for patients who do not search for information on the
Internet themselves. In contrast, paper-based SCPs do not seem
beneficial for patients who do search for disease-related
information on the Internet. With the increasing importance of
the Internet as a source of information for cancer survivors,
future research needs to examine whether dissemination of
tailored online SCPs may have added value for patients who
use the Internet to obtain disease-related information.
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